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Introduction 
Septicemia is a severe pathologic condition that arises when a source of infection 
becomes systemic – finding its way to multiple organ systems via the blood. It is clinically 
defined by the presence of two or more systemic inflammatory response syndrome (SIRS) 
criteria accompanied by suspected infection or infection (Francis, Rich, Williamson, & Peterson, 
2010). Patients presenting with sepsis or septic shock progress rather quickly to serious states, 
and if left untreated, may rapidly progress to death. Even with treatment, it is estimated mortality 
rates for patients with severe sepsis are between 30% and 50% (Stoneking, Denninghoff, Deluca, 
Keim, & Munger, 2011). The severity of this condition makes it apparent that it is a major 
disease process facing our healthcare system. Over 750,000 new cases of sepsis and septic shock 
present each year in the United States accounting for 215,000 deaths annually or 9.3% of all 
deaths in the United States yearly (Stoneking et al., 2011).  
  Given the above facts, it is surprising to learn that septic shock has been recognized 
since the earliest days of modern medicine (Puskarish, 2012). Only in recent times, however, has 
the importance of early recognition and treatment of sepsis emerged. In 2001, a landmark study 
in the treatment of sepsis was released in which researchers were able to reduce the mortality rate 
due to sepsis by 16% using a form of bundled care called early goal directed therapy (EGDT) 
created by researchers Rivers et. al. (Vorwerk & Coats, 2011). Patient care bundles consist of “a 
set of interventions or processes of care distilled from evidence-based practice guidelines that 
when implemented as a group, provide a more robust picture of the quality of care provided” 
(Thomas, 2007, p. 1211). Thus, bundled care sets are based upon scientifically sound 
interventions, with a cohesive shared focus, and directly relatable to metrics of quality of care. 
The key to bundled care sets that differentiate them from typical care guidelines and protocols 
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lies in their comprehensive nature. Their purposive effects are gathered not only from each 
individual intervention, but the additive and interactive effects of using interventions en masse 
(Puskarich, 2012). In the case of sepsis, this care bundle took the form of Rivers’s EGDT, which 
emphasized early recognition and treatment of sepsis. In fact, Rivers’s EGDT was so successful 
that the EGDT concept was adopted by the Surviving Sepsis Campaign (SSC), an international 
cooperation of the world’s leading organizations dealing with sepsis. The aim of the SSC is to 
improve the diagnosis, management, and survival of patients with sepsis. In 2004, they released 
guidelines for hospitals to base their care bundles upon, with the express goal of decreasing 
sepsis mortality by 25% by the year 2009 (Francis et al., 2010).  
 Since the SSC’s formation, several studies have shown markedly improved outcomes 
with the use of emergency department (ED) based sepsis protocols. Using EGDT guidelines has 
allowed clear identification and quick treatment of sepsis to improve patient outcomes and 
mortality rates (Casserly et al., 2011; Francis et al., 2010; Larsen, Mecham, Greenberg, 2011; 
Patel, Roderman, Gehrig, Saad, & Bartek, 2010; Puskarish et al., 2011; Sweet et al., 2010; 
Uusitalo-Seppal et al., 2011).  
Despite the evidence of the effectiveness of EGDT in reducing morbidity and mortality, a 
survey given to physicians at 30 academic tertiary care EDs, revealed only 7% of clinicians used 
EGDT (Stoneking et al., 2011). Additionally only one study conducted by Casserly and 
coworkers (2011) has been published in which EGDT care bundle was incorporated into the care 
of septic patients in the intensive care unit (ICU).  Casserly’s study created a collaborative 
approach in which most critically ill patients with sepsis were transferred from the ED to the ICU 
as quickly as possible to receive intensive EGDT bundled care as soon as possible. Their data 
suggests “the use of a collaborative protocol for sepsis intervention may decrease the time to 
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initiation of resuscitation for patients admitted to the ED with severe sepsis and decrease the time 
to transfer to the ICU.” (Casserly et al., 2011) 
Another very important and pertinent factor affecting all health care is cost. Many 
healthcare facilities are resistant to changes in care that increase cost when the trend nationally is 
to reduce costs as much as possible. A study by Jones et al (2011) found that the use of an EGDT 
increases direct hospital cost by $7028 per patient. But after performing a net monetary benefit 
analysis the researchers found with a 98% probability that EGDT was cost effective (Jones, 
2011). This suggests that while initial costs of EGDT implementation are higher, the long term 
and overall benefits actually outweigh that cost in value. 
An ad hoc committee of specialists at the study hospital developed the Sepsis Powerplan 
that was implemented. Dr. Buddy Newton, Medical Director of Antimicrobial Stewardship, laid 
the foundation for the plan based upon his vast experience and knowledge of the revisions to the 
SSC guidelines. This foundation was expanded upon and turned into an all inclusive multiple 
step plan of action by the committee consisting of Dr. David Ratcliff – Chief Medical Officer of 
the hospital, Dr. Kyle Hardy – Medical Director of ICU, Terri Church – nurse informaticist, 
Rebecca Cowie – critical care CNS, Sheryl Davis – Critical Care Director and CNS, and Teri 
Hayden – ED director (personal communication, 2013). 
Specific Aims 
The purpose of this prospective pre and post design study was to corroborate the 
effectiveness of EGDT care bundles as the standard of treatment in an urban hospital by 
evaluating the care of patients presenting to the ED with septic shock and to gather further data 
relating to collaboration between the ED and ICU in EGDT care bundles dealing with septic 
patients. Primary variables of interest included time to: fluid administration, vasopressor 
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administration, catheter insertion, initial antibiotics, and transfer to ICU - along with mortality 
rates and length of hospital stay.  These data combined with that relating to compliance help to 
answer the question: Can sepsis EGDT be implemented in an urban hospital, with no prior 
experience in using a treatment protocol for septic patients, to benefit those patients? The 
primary focus of this research, then, is to determine if there is a difference between the pre and 
post implementation populations in the key variables of interest. 
Methods 
Approval was received from the hospital’s quality improvement board and the University 
of Arkansas’s institutional review boards (IRB) before the commencement of this study.  
Sample	  	  This	  study	  used	  non-­‐random	  selection	  to	  divide	  its	  subjects	  into	  two	  groups:	  that	  of	  pre-­‐implementation	  and	  that	  of	  post	  implementation.	  The	  post-­‐implementation	  sample	  for	  this	  study	  consisted	  of	  all	  patients	  admitted	  to	  the	  ED	  between	  May	  2013	  and	  October	  2013	  with	  an	  admitting	  diagnosis	  of	  sepsis/septic	  shock	  and	  who	  were	  administered	  the	  Sepsis	  Powerplan	  care	  bundle.	  	  Information	  was	  compared	  to	  corresponding	  patient	  data	  for	  the	  same	  6	  month	  frame	  of	  the	  preceding	  year	  (2012)	  prior	  to	  implementation	  of	  the	  full	  care	  bundle	  as	  the	  pre-­‐implementation	  group.	  In	  the	  context	  of	  this	  study,	  a	  diagnosis	  of	  sepsis	  in	  a	  patient	  was	  established	  with	  the	  presence	  of	  two	  or	  more	  of	  the	  following	  SIRS	  indicators: 
• Temperature  <96.8 F or >100.4 F 
• Respiratory Rate >20 
• Heart rate >90 
• White Blood Count <4000 or >12000 OR  >10% bands 
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• Systolic blood pressure <90, Glucose >150 in absence of Diabetes Mellitus 
• Urine output < 35 cc/ hr (non hemodialysis patient) 
• Altered mental status (acute), O2 saturation <92% on room air, or Lactate >4.0]  
• A known or suspected infection (determined by treating physician) 
For the purpose of this study, sepsis organ dysfunction was determined on a case by case basis 
by the physician in charge of the case based upon data obtained through lab tests as indicated by 
the Sepsis Powerplan. 
Design  
This study was constructed as a retrospective review prior to the implementation of the 
Sepsis Powerplan and a prospective review post implementation.  Data from the 6 month period 
of patients with sepsis in 2012 served as the control and the data from the corresponding 6 
months in 2013 served as the test group. 
Variables  
This study analyzed the following among both control and test groups: 
• Time from admission to first fluid administration in minutes 
• Time from admission to first vasopressor administration in minutes 
• Time from admission to central venous arterial pressure (CVAP) catheter insertion in 
minutes 
• Time from admission to initial antibiotics administration in minutes 
- Specific antibiotic administered 
- Whether a culture and sensitivity was drawn before antibiotic administered 
• Time from admission to transfer to ICU (if necessary) in minutes 
• Mortality Rates 
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• Length of hospital stay in days 
• Compliance with bundle among providers as measured through documentation of all 
portions of Sepsis Powerplan administered 
Procedure  
The Sepsis Powerplan was administered to all patients presenting to the ED at the study 
hospital who met the definition of sepsis. For these patients, admission to the ICU was 
considered at the discretion of the physician in charge. Patients with severe sepsis, consisting of 
the presence of two SIRS indicators plus one or more indicators of ‘sepsis-related’ organ 
dysfunction were admitted to the ICU. All patients in septic shock –presenting with the two 
sepsis indicators and hypotension unresponsive to appropriate fluid resuscitation were admitted 
to the ICU. All patients were administered the care bundle and all data in the variables listed 
came from the study hospital’s medical records. 
Data Analysis  
To ensure the privacy of patients and staff, all data was de-identified according to HIPPA 
guidelines for research. Each patient record was assigned a four digit alphanumeric code. The 
first digit was either an S, indicating the patient is in the pre-implementation population, or an I, 
indicating the patient is in the post implementation population, while the second digit will 
indicate which floor [1-5] the patient was on in the hospital. The final two digits were a unique, 
randomized two digit patient identifier number [00 – 99]. Data was collected for a 6 month span 
from May 2013 – October 2013 for the post implementation. Corresponding data from the same 
6 month frame of the preceding (2012) year were examined as the pre implementation data. 
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Results 
The control group inclusionary criteria netted 39 patients, while the test group yielded 31 
patients. Results were analyzed in a between-groups design, using two tailed t tests, z tests of 
proportions, and a Kruskal-Wallis one way ANOVA – all with an alpha level of 0.05 and the null 
hypothesis in all cases being that there was no difference between the test group and the control 
group. Two tailed t tests of time to fluid administration, t = 1.504, p = 0.137 with df = 68; time to 
vasopressor administration, t = 0.355, p = 0.729 with df = 11; time to antibiotic administration, t 
= 1.476, p = 0.145 with df = 68; time to ICU transfer, t = 0.555, p = 0.587 with df = 16; and 
length of hospital stay, t = 0.545, p = 0.587 with df = 68; failed to reveal a significant difference 
in the means between groups. Figures 1 and 2 show the similarity in means for these variables. A 
t test on time to central venous/arterial pressure (CVAP) catheter insertion was impossible due to 
insufficient data. Z tests of proportions on antibiotic culture and sensitivity obtainment, z = -
1.836, p = 0.0658; and on mortality, z = 1.836, p = 0.0658 failed to reveal a significant effect. 
Figure 3 graphs the proportions for these variables. A Kruskal-Wallis one way ANOVA for 
categorical data revealed a significant effect for group on mortality, chi-squared = 114.24, p = 
0.0000 with df = 1, indicating that variance in mortality can be accounted for by variance in the 
group. Therefore, according to t test results and z test results, the null hypothesis fails to be 
rejected while, according to the modified one way ANOVA, the null hypothesis is rejected.  
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This study’s primary limitation is that of time. Since the inclusion criteria is anyone 
presenting to the ED at the facility of interest with SIRS indicators indicating a diagnosis of 
sepsis over certain time frames for both pre and post implementation groups, a longer time of 
study is necessary to have a larger sample size. A larger sample size would better reflect the 
distribution of key variables amongst both pre and post populations, potentially yielding more 
statistically relevant information. Another crucial limitation is that the design of the study was 
created using an early draft of the implemented treatment protocol. Thus, data over some 
variables of interest to the protocol was not collected while certain data over variables that were 
actually collected was done so in a limited fashion, for example being categorical as opposed to 
comparatively numerical. This results in a narrowing in the scope of this study as less relevant 
information can be presented. The final limitation of the study is that a clear start time of patient 
-­	  7	  -­	  Post	  antibiotic	  administration	  frequencies	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care was hard to identify given the provided documentation. In order to quantify how long it took 
for a given patient to receive fluid or antibiotics, not only is the time of administration required, 
so too is a clear time zero. This was not the case, however, as identifying exactly when a patient 
presented to the health system proved difficult as this factor was not defined in ED 
documentation and because mode of arrival to the ED varied between ambulance, where 
sometimes treatment would begin en route, and self transport, where treatment would not begin 
until after triage in the ED. 
Discussion 
Data was collected on all patients who presented to the facility of interest’s ED meeting 
SIRS criteria for an initial diagnosis of sepsis. The pre-implementation group consisted of 39 
patients who came into the ED between May and October of 2012 while the post-implementation 
group was made up of 31 patients who presented during the same months in 2013. Ultimately, 
the statistical analysis of data reveals that the only statistically significant difference between the 
pre-implementation and post-implementation groups occurs in regards to mortality. This in itself 
may demonstrate that the protocol had a significant impact on patient outcome.  Yet, there is 
more to the data than just the final values of the statistical tests. 
Comparison of Means 
Figures 1 and 2 provide a clear illustration of the means of several variables of interest. 
With the first variable, time to fluid administration, it is interesting to see that, despite being 
statistically insignificant, the mean actually increased in the post-implementation group. There is, 
however, an outlier in the post-implementation group where fluids were not administered until 
much later in treatment (14.7 hours), when the patient was already on the floor. Since the sample 
sizes of both the control and test group are so small, it is worth analyzing the data sets with the 
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removal of the outlier to see if there was actually an effect on fluid administration time by the 
sepsis treatment protocol.  Doing so lowers the mean in the test group to 137.93 and a t test 
comparing those means and the modified data sets yields t = .983 and p = .329, so the change is 
still statistically insignificant. Further study is required to identify what factors would potentially 
cause fluid administration time to increase in the test group.  
In the second variable of interest, time to vasopressor administration, the mean time 
dropped from 981 minutes in the control group to 788 in the test group. But, the sample size for 
this variable is even smaller then the overall sample size for both groups because only those who 
clinically required vasopressors had them administered. This consisted of 6 patients in the 
control group and 7 in the test group. Because these numbers are so small, there is an extremely 
high degree of standard error in the means and it is no surprise that the difference in them is not 
statistically significant.  
The next variable of interest, time to antibiotic administration, has a much lower, though 
statistically insignificant, average in the post-implementation group at 214 minutes than in the 
pre-implementation group at 368 minutes. As with fluid administration time, there was an outlier 
in the post-implementation data set where for an unknown reason antibiotic administration was 
delayed. Removal of this outlier lowers the post-implementation average further to 194 minutes. 
A t test on the modified data set yields t = 1.663 and p = .101 which is still statistically 
insignificant with an alpha level of 0.05. Though it is statistically insignificant it is a good 
indicator for the hospital that mean antibiotic administration time dropped so much between 
groups. It represents a step in the right direction and further analysis may reveal factors that lead 
to decreased antibiotic administration time that can be applied to fluid administration in order to 
decrease that time in the future. It is worth noting here that the updated SSC standards propose 
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rapid antibiotic administration and hemodynamic support with EGDT be accomplished within 
the first three hours of treatment (Dellinger et al., 2013). The hospital of interest falls within that 
guideline on fluid administration, but falls just shy of this standard for antibiotic administration. 
Further study into how other facilities decrease overall time to antibiotic administration is 
necessary to identify such practices and implement them in the facility of interest to further 
reduce antibiotic administration time.  
With the next variable, time to ICU transfer, the average in the post-implementation 
group is about 20 minutes higher at 276 minutes than that of the pre-implementation group at 
255 minutes. This difference was shown to be statistically insignificant and with approximately 
no difference in the standard error of the means it is safe to say that there is no meaningful 
difference between the two groups in that regard. It is interesting to note that the implemented 
Sepsis Powerplan is divided into two phases, mirroring the 2012 SSC guidelines of initially 
providing fluid resuscitation and antibiotics before moving on to more complex treatments like 
vasopressors and other hemodynamic therapies. The SSC’s goals are to have the first phase of 
treatment be completed within three hours and the second to occur within six hours (Dellinger et 
al., 2013), while the facility of interest’s goal is to do phase one in the ED and complete phase 
two in the ICU. In order to accomplish that goal then, further research must be done to identify 
and implement ways to decrease time in ED as the current time of approximately five hours to 
ICU is simply too long for the treatment protocols.  
The final variable with means to compare is the length of hospital stay in days. The mean 
for the control group was 8.92 while the test group was 8.26. As this difference is statistically 
insignificant and the standard error of the means is approximately equal, it is safe to say that 
EGDT had no effect on the length of stay in this hospital. However, according to a CDC study in 
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2008 (Hall, Williams, DeFrances, & Golosinskiy, 2011), the average length of stay for those 
hospitalized for sepsis is 8.4 days. By this marker, the study hospital is just under the national 
average.  
Comparison of Proportions and Frequencies 
Figure 3 clearly shows that there is a difference between both groups when it comes to 
blood culture and sensitivity obtainment and mortality. In the pre-implementation group, 10% of 
patients did not have their blood cultures drawn before antibiotic administration while in the post 
implementation group, 0% of patients did not have their blood cultures drawn prior to antibiotic 
administration. At the same time, 10% of patients died in the pre-implementation group while 
0% died in the post-implementation group. With a significance level of 95%, these results prove 
statistically insignificant since z tests result in a p value of .0658 for both. Yet, having no deaths 
in the post-implementation group is definitely noteworthy. If the significance level is dropped to 
just below 93.42%, these values are meaningful and the null hypothesis would be rejected. 
Therefore, accepting a 93% confidence level (as opposed to 95%) would have concluded that the 
difference in proportions for blood culture obtainment and mortality between groups did not 
occur by chance. This alone can’t lead to the conclusion that the EGDT protocol directly caused 
these things to happen, but it is reasonable to presume that the protocol plus staff awareness and 
all other environmental factors post-implementation are leading to conditions in which blood 
cultures are taken more frequently and patients are dying less frequently. Further study is of 
course needed to verify this.  
 In conducting this study, data was collected not only on when antibiotics were 
administered but which antibiotics were administered first. Figure 4 shows the percentages with 
which different types of antibiotics were given and Figures 5 and 6 show these values as 
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percentages of the whole. The treatment protocol calls for a shotgun approach initially, that is 
using multiple broad spectrum antibiotics while blood cultures are running, before switching to 
more specific drug. According to the protocol, patients should receive the following antibiotics 
sequentially before switching to something more bacteria specific: meropenem, vancomycin, and 
levofloxacin. Unsurprisingly, most patients in the control group received a variety of antibiotics 
other than those three. Of interest is the proportion that actually received meropenem first in the 
test group. As can be seen in Figure 4 that is only about 19%, which is curious considering that it 
should be 100%.  Further analysis as to why this occurred is necessary. Further education over 
the protocol may be necessary for those using it. 
Analysis of Variance 
Because 0% of patients in the post-implementation group died, while 10.2% of patients 
died in the pre-implementation group, a Kruskal-Wallis one-way ANOVA for categorical 
information was conducted to see if the variation in the group truly accounts for the variation in 
mortality. This test gets to the heart of this study as it attempts to say whether being in the pre or 
post group had an effect on whether or not a patient died. Since the p-value of this test is so low 
that it is essentially zero, the null hypothesis of equal variance per group was rejected at an alpha 
level of .0001. Because of this, it can be said with confidence that the variance in the group 
accounts for the variance in the mortality. As variance in group can only be pre and post and the 
variance in mortality can only be yes or no, then it can be said in this study with certainty that 
which group a patient was in does help to explain whether or not they died. While other factors 
could account for this and further analysis is necessary to say for sure due to the small number of 
subjects, this is a strong indication that EGDT at this hospital has indeed been effective at 
reducing mortality.  
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Recommendations 
The scope of this study is limited to the hospital in which it took place, so 
recommendations based on this study’s analysis will be aimed at this target hospital. Since the 
major weakness of this study is that the sample sizes are too low, in order for the hospital to 
determine whether or not its treatment protocol is having an effect on patient outcomes is to have 
continual monitoring with review. This will ultimately determine whether or not the trends seen 
by this study continue because eventually, the sample size of the post-implementation patients 
will become large enough to determine statistically significant differences on variables of 
interest. It is also recommended that the hospital continue to frequently educate its healthcare 
professionals on the treatment protocols. This is a new protocol implemented earlier this year, 
and given the low percentage of patients who received the appropriate first antibiotic in the test 
group, it is assumed that those using the protocol may not be familiar with it. Other more specific 
recommendations include: individual chart review for outlier patients to determine why indeed 
those patients were outliers, identifying systemically factors that would cause fluid 
administration time to increase with protocol implementation, and identification and 
implementation of methods to reduce overall antibiotic administration times and time spent in 
the ED before ICU transfer. 
The Sepsis Powerplan is an important protocol which may prove to increase the 
identification and treatment of patients experiencing septicemia. It may have a major impact on 
overall mortality rates in these high risk patients. Implementation of such a protocol needs 
continuous evaluation for compliance with implementation guidelines to maximize its impact on 
patient care.  
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